Overview
FabiFlu 200 mg contains Favipiravir, an antiviral medication originally developed for treating influenza infections. It was later approved in some countries for mild to moderate COVID-19 cases. Favipiravir works by inhibiting viral RNA polymerase, preventing the replication of the virus inside the body.





